{"id":94,"date":"2016-01-25T22:37:04","date_gmt":"2016-01-25T22:37:04","guid":{"rendered":"http:\/\/dev.msapr.com\/main\/?page_id=94"},"modified":"2026-04-30T16:57:36","modified_gmt":"2026-04-30T16:57:36","slug":"interviews","status":"publish","type":"page","link":"https:\/\/www.msapr.com\/main\/interviews\/","title":{"rendered":"Interviews"},"content":{"rendered":"<div id=\"mainmodules2\" class=\"spacer w99\">\n<div class=\"block\">\n<div class=\"moduleInterview\">\n<div>\n<div>\n<div>\n<div id=\"gk_npro-Interview\" class=\"gk_npro_mainwrap\">\n<div class=\"gk_npro_full\">\n<div class=\"gk_npro_full_scroll1\">\n<div class=\"gk_npro_full_scroll2\">\n<div class=\"gk_npro_full_tablewrap\">\n<div style=\"width:650px; margin:0 auto;\">\n<h2>The list of recent interview articles<\/h2>\n<p><strong><a href=\"\/main\/interview-archives-before-2025\/\">Archive Interviews before 2025<\/a><\/strong><\/p>\n<div style=\"margin-bottom:10px; border:1px solid #fff; padding:10px;\">\n<h5>Issue 1039: April 11, 2025<\/h5>\n<p><strong><img decoding=\"async\" class=\"interview\" src=\"https:\/\/www.msapr.com\/main\/wp-content\/uploads\/2025\/04\/1039-scaled.jpg\" alt=\"1039\" height=\"75\" \/>William Korinek, Ph.D. and Theodore Liston, Ph.D.,<\/strong> CEO and Co-Founder of Astrocyte Pharmaceuticals and Vice-President of Research at Astrocyte Pharmaceuticals, on Pioneering a New Treatment for Injuries to the Brain by Targeting Astrocytes.\n<\/div>\n<div style=\"margin-bottom:10px; border:1px solid #fff; padding:10px;\">\n<h5>Issue 1037: March 28, 2025<\/h5>\n<p><strong><img decoding=\"async\" class=\"interview\" src=\"https:\/\/www.msapr.com\/main\/wp-content\/uploads\/2025\/04\/1037.jpg\" alt=\"1037\" height=\"75\" \/>W. David Arnold, M.D.,<\/strong> Executive Director of the NextGen Precision Health initiative, Professor of Physical Medicine and Rehabilitation,\u202fNeurology and Medical Pharmacology and Physiology, University of Missouri, on developing a novel potential therapy for age-related weakness.<\/p>\n<\/div>\n<div style=\"margin-bottom:10px; border:1px solid #fff; padding:10px;\">\n<h5>Issue 1034: February 28, 2025<\/h5>\n<p><strong><img decoding=\"async\" class=\"interview\" src=\"https:\/\/www.msapr.com\/main\/wp-content\/uploads\/2025\/04\/1034-1.jpg\" alt=\"1034-1\" height=\"75\" \/><img decoding=\"async\" class=\"interview\" src=\"https:\/\/www.msapr.com\/main\/wp-content\/uploads\/2025\/04\/1034-2.jpg\" alt=\"1034-2\" height=\"75\" \/> Etienne Sibille, Ph.D. and Thomas Prevot, Ph.D.,<\/strong> Scientific Director of the Neurobiology of Depression and Aging Program and the Campbell Chair at the Campbell Family Mental Health Research Institute of the Centre for Addiction and Mental Health and Staff Scientist at the Neurobiology of Depression and Aging Program at the Campbell Family Mental Health Research Institute of the Centre for Addiction and Mental Health, on developing a breakthrough drug with the potential to treat cognitive dysfunction in Alzheimer&#8217;s disease.<\/p>\n<\/div>\n<div style=\"margin-bottom:10px; border:1px solid #fff; padding:10px;\">\n<h5>Issue 1033: February 21, 2025<\/h5>\n<p><strong><img decoding=\"async\" class=\"interview\" src=\"https:\/\/www.msapr.com\/main\/wp-content\/uploads\/2025\/04\/1036.jpg\" alt=\"1036\" height=\"75\" \/> Nadav Ahituv, Ph.D.,<\/strong> Professor, Department of Bioengineering and Therapeutic Sciences, Director, Institute for Human Genetics, University of California San Francisco, on engineering fat cells to suppress tumor cells.\n<\/div>\n<div style=\"margin-bottom:10px; border:1px solid #fff; padding:10px;\">\n<h5>Issue 1031: February 7, 2025<\/h5>\n<p><strong><img decoding=\"async\" class=\"interview\" src=\"https:\/\/www.msapr.com\/main\/wp-content\/uploads\/2025\/04\/1031.jpg\" alt=\"1031\" height=\"75\" \/>Sherri Oberg,<\/strong> CEO and Co-Founder of Particles for Humanity, on developing a solution for the historic issue of instability in vitamin A to treat vitamin A deficiency in areas with high unmet need.\n<\/div>\n<div style=\"margin-bottom:10px; border:1px solid #fff; padding:10px;\">\n<h5>Issue 1030: January 31, 2025<\/h5>\n<p><strong><img decoding=\"async\" class=\"interview\" src=\"https:\/\/www.msapr.com\/main\/wp-content\/uploads\/2025\/04\/1030.jpg\" alt=\"1030\" height=\"75\" \/> Flaura Winston, M.D., Ph.D.,<\/strong> Director of the Innovation Ecosystem Initiative, Children\u2019s Hospital of Philadelphia, on bringing an entrepreneurial perspective to academia.\n<\/div>\n<div style=\"margin-bottom:10px; border:1px solid #fff; padding:10px;\">\n<h5>Issue 1029: January 24, 2025<\/h5>\n<p><strong><img decoding=\"async\" class=\"interview\" src=\"https:\/\/www.msapr.com\/main\/wp-content\/uploads\/2025\/04\/1029.jpg\" alt=\"1029\" height=\"75\" \/>Evonne Sepsis,<\/strong> Founder and Managing Partner of ESC Advisors, on getting biotech clinical assets to a value inflection point.\n<\/div>\n<div style=\"margin-bottom:10px; border:1px solid #fff; padding:10px;\">\n<h5>Issue 1028: January 17, 2025<\/h5>\n<p><strong><img decoding=\"async\" class=\"interview\" src=\"https:\/\/www.msapr.com\/main\/wp-content\/uploads\/2025\/03\/1028.png\" alt=\"1028\" height=\"75\" \/>B. Frank Gupton, Ph.D.,<\/strong> Chief Executive Officer, Medicines for All Institute at Virginia Commonwealth University, on eliminating waste and inefficiency in the drug manufacturing process.\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The list of recent interview articles Archive Interviews before 2025 Issue 1039: April 11, 2025 William Korinek, Ph.D. and Theodore Liston, Ph.D., CEO and Co-Founder of Astrocyte Pharmaceuticals and Vice-President of Research at Astrocyte Pharmaceuticals, on Pioneering a New Treatment for Injuries to the Brain by Targeting Astrocytes. Issue 1037: March 28, 2025 W. David [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-94","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.msapr.com\/main\/wp-json\/wp\/v2\/pages\/94","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.msapr.com\/main\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.msapr.com\/main\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.msapr.com\/main\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.msapr.com\/main\/wp-json\/wp\/v2\/comments?post=94"}],"version-history":[{"count":102,"href":"https:\/\/www.msapr.com\/main\/wp-json\/wp\/v2\/pages\/94\/revisions"}],"predecessor-version":[{"id":780,"href":"https:\/\/www.msapr.com\/main\/wp-json\/wp\/v2\/pages\/94\/revisions\/780"}],"wp:attachment":[{"href":"https:\/\/www.msapr.com\/main\/wp-json\/wp\/v2\/media?parent=94"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}